DnB Asset Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$145M Buy
536,703
+98,774
+23% +$29.4M 0.52% 33
2025
Q4
$145M Buy
437,929
+48,691
+13% +$16.5M 0.5% 32
2025
Q3
$134M Buy
389,238
+9,513
+3% +$2.88M 0.5% 31
2025
Q2
$118M Buy
379,725
+47,936
+14% +$18.3M 0.49% 37
2025
Q1
$174M Buy
331,789
+61,031
+23% +$31.2M 0.8% 23
2024
Q4
$137M Buy
270,758
+23,391
+9% +$13.3M 0.59% 25
2024
Q3
$145M Sell
247,367
-2,331
-0.9% -$1.32M 0.65% 26
2024
Q2
$127M Buy
249,698
+38,759
+18% +$19M 0.61% 29
2024
Q1
$104M Sell
210,939
-72,441
-26% -$36.8M 0.54% 34
2023
Q4
$149M Buy
283,380
+9,138
+3% +$4.87M 0.77% 21
2023
Q3
$138M Sell
274,242
-1,061
-0.4% -$522K 0.83% 20
2023
Q2
$132M Buy
275,303
+7,074
+3% +$3.46M 0.76% 23
2023
Q1
$127M Buy
268,229
+29,177
+12% +$14.1M 0.8% 23
2022
Q4
$127M Buy
239,052
+11,060
+5% +$5.86M 0.89% 20
2022
Q3
$115M Buy
227,992
+3,598
+2% +$1.89M 0.89% 21
2022
Q2
$115M Buy
224,394
+930
+0.4% +$467K 0.81% 23
2022
Q1
$114M Buy
223,464
+9,814
+5% +$4.73M 0.68% 29
2021
Q4
$107M Buy
213,650
+9,590
+5% +$4.34M 0.63% 28
2021
Q3
$79.7M Buy
204,060
+8,858
+5% +$3.67M 0.52% 33
2021
Q2
$78.2M Buy
195,202
+25,298
+15% +$10.1M 0.52% 32
2021
Q1
$63.2M Buy
169,904
+2,324
+1% +$805K 0.46% 37
2020
Q4
$58.8M Buy
167,580
+44,029
+36% +$14.8M 0.52% 36
2020
Q3
$38.5M Sell
123,551
-61,499
-33% -$18.9M 0.41% 48
2020
Q2
$54.6M Buy
185,050
+3,221
+2% +$923K 0.64% 31
2020
Q1
$45.3M Sell
181,829
-21,358
-11% -$5.88M 0.67% 28
2019
Q4
$59.7M Buy
203,187
+51,563
+34% +$13.5M 0.59% 33
2019
Q3
$33M Sell
151,624
-10,257
-6% -$2.47M 0.37% 51
2019
Q2
$39.5M Sell
161,881
-4,563
-3% -$1.1M 0.45% 45
2019
Q1
$41.2M Sell
166,444
-19,881
-11% -$5.07M 0.47% 46
2018
Q4
$46.4M Buy
186,325
+65,845
+55% +$17.4M 0.6% 39
2018
Q3
$32.1M Sell
120,480
-314,359
-72% -$81.8M 0.36% 58
2018
Q2
$107M Sell
434,839
-14,300
-3% -$3.43M 1.26% 16
2018
Q1
$96.1M Buy
449,139
+56,400
+14% +$12.9M 1.16% 18
2017
Q4
$86.6M Sell
392,739
-58,663
-13% -$12.4M 1.04% 24
2017
Q3
$88.4M Sell
451,402
-50,100
-10% -$9.68M 1.18% 19
2017
Q2
$93M Buy
501,502
+11,000
+2% +$1.93M 1.36% 16
2017
Q1
$80.4M Sell
490,502
-97,100
-17% -$15.9M 1.26% 15
2016
Q4
$94M Buy
587,602
+14,100
+2% +$2.11M 1.73% 11
2016
Q3
$80.3M Sell
573,502
-400
-0.1% -$56K 1.58% 14
2016
Q2
$81M Buy
573,902
+27,800
+5% +$3.71M 1.72% 13
2016
Q1
$70.4M Buy
546,102
+450,500
+471% +$53.3M 1.47% 16
2015
Q4
$11.2M Buy
95,602
+26,200
+38% +$3.06M 0.24% 86
2015
Q3
$8.05M Sell
69,402
-11,300
-14% -$1.35M 0.2% 98
2015
Q2
$9.85M Sell
80,702
-31,000
-28% -$3.67M 0.22% 93
2015
Q1
$13.2M Sell
111,702
-27,500
-20% -$3.05M 0.29% 72
2014
Q4
$14.1M Sell
139,202
-24,700
-15% -$2.34M 0.32% 67
2014
Q3
$14.1M Buy
163,902
+36,700
+29% +$3.1M 0.31% 63
2014
Q2
$10.4M Buy
+127,202
New +$10M 0.22% 85
2013
Q4
$8.31M Buy
110,302
+85,700
+348% +$6.16M 0.2% 100
2013
Q3
$1.76M Sell
24,602
-41,566
-63% -$2.97M 0.05% 163
2013
Q2
$4.33M Buy
+66,168
New +$4.12M 0.13% 94

Other funds holding UNH

DnB Asset Management's UNH Position: Q1 2026 in Review

DnB Asset Management increased its UnitedHealth (UNH) stake by 23% in Q1 2026, buying an estimated $29.4M and bringing the position to 536,703 shares worth $145M. The position accounts for 0.52% of the portfolio, ranked #33.

DnB Asset Management first reported a position in UNH in Q2 2013 and has held it in 51 quarters since. The position peaked at $174M in Q1 2025. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • DnB Asset Management held 536,703 shares of UnitedHealth worth $145M as of Q1 2026.
  • DnB Asset Management bought 98,774 UnitedHealth shares in Q1 2026, an estimated $29.4M.
  • UnitedHealth made up 0.52% of DnB Asset Management's portfolio in Q1 2026, its #33 holding.
  • DnB Asset Management first reported a position in UnitedHealth in Q2 2013 and has held it in 51 quarters since.
  • DnB Asset Management's UnitedHealth position peaked at $174M in Q1 2025.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.